Results 31 to 40 of about 36,032 (319)

Design and validation of a novel multi-epitopes vaccine against hantavirus

open access: yesJournal of Biomolecular Structure and Dynamics, 2023
Hantavirus is a member of the order Bunyavirales and an emerging global pathogen. Hantavirus infections have affected millions of people globally based on available epidemiological data and research studies. Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are the two main human diseases associated with hantavirus ...
Taghreed N. Almanaa   +8 more
openaire   +2 more sources

Bioinformatics analysis for the purpose of designing a novel multi-epitope DNA vaccine against Leishmania major

open access: yesScientific Reports, 2022
Leishmaniasis is one of the main infectious diseases worldwide. In the midst of all the different forms of the disease, Cutaneous Leishmania (CL) has the highest incidence in the world.
Sama Rashidi   +7 more
doaj   +1 more source

In silico design of a multi-epitope vaccine against HPV16/18

open access: yesBMC Bioinformatics, 2022
Abstract Background Cervical cancer is the fourth most common cancer affecting women and is caused by human Papillomavirus (HPV) infections that are sexually transmitted. There are currently commercially available prophylactic vaccines that have been shown to protect vaccinated individuals against HPV infections, however,
Samira Sanami   +9 more
openaire   +3 more sources

Evidence for conservation in antigen gene sequences combined with extensive polymorphism at VNTR loci [PDF]

open access: yes, 2020
Theileria parva is a tick‐transmitted apicomplexan protozoan parasite that infects lymphocytes of cattle and African Cape buffalo (Syncerus caffer), causing a frequently fatal disease of cattle in eastern, central and southern Africa.
Ahmed, Jabbar   +13 more
core   +1 more source

Design of a multi-epitope vaccine candidate against Brucella melitensis

open access: yesScientific Reports, 2022
AbstractBrucella is a typical facultative intracellular bacterium that can cause zoonotic infections. For Brucella, it is difficult to eliminate with current medical treatment. Therefore, a multi-epitope vaccine (MEV) should be designed to prevent Brucella infection. For this purpose, we applied the reverse vaccinology approach from Omp10, Omp25, Omp31
Min Li   +9 more
openaire   +3 more sources

Protective multi-epitope candidate vaccine for urinary tract infection

open access: yesBiotechnology Reports, 2020
Urinary tract infections (UTIs) are induced by exogenous organisms including extraintestinal pathogenic such as Escherichia coli (ExPEC), Proteus mirabilis and Klebsiella pneumonia, which are closely related. These organisms can colonize in the urinary tract and cause UTIs.
Jamil Kheirvari Khezerloo   +5 more
openaire   +4 more sources

Influenza Evolution and H3N2 Vaccine Effectiveness, with Application to the 2014/2015 Season [PDF]

open access: yes, 2016
Influenza A is a serious disease that causes significant morbidity and mortality, and vaccines against the seasonal influenza disease are of variable effectiveness.
Deem, Michael W., Li, Xi
core   +2 more sources

Development of a Novel Multi-Epitope Vaccine Candidate against Streptococcus Iniae Infection in Fish: An Immunoinformatics Study [PDF]

open access: yesArchives of Razi Institute, 2022
Streptococcus iniae infection is recognized as a disease with substantial economic losses, infecting a wide range of fish species. The limitations of current vaccines and strategies have led to the identification of new methods to control this disease ...
Ali Forouharmehr   +3 more
doaj   +1 more source

Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses. [PDF]

open access: yes, 2018
Nanoparticles have attracted considerable interest as cancer vaccine delivery vehicles for inducing sufficient CD8+ T cell-mediated immune responses to overcome the low immunogenicity of the tumor microenvironment.
Kim, Tae Il   +5 more
core   +2 more sources

Analogue peptides for the immunotherapy of human acute myeloid leukemia [PDF]

open access: yes, 2015
Accepted manuscript. The final publication is available at: http://link.springer.com/article/10.1007%2Fs00262-015-1762-9The use of peptide vaccines, enhanced by adjuvants, has shown some efficacy in clinical trials.
A Driessche Van   +102 more
core   +1 more source

Home - About - Disclaimer - Privacy